{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:30:42Z","timestamp":1790501442446,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":2444,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1111\/jth.13243","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T08:41:34Z","timestamp":1451378494000},"page":"449-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Developments in the diagnostic procedures for von Willebrand disease"],"prefix":"10.1016","volume":"14","author":[{"given":"A.","family":"De Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Eikenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13243_bb0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pbc.22429","article-title":"A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population","volume":"55","author":"Bowman","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/jth.13243_bb0020","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"10.1111\/jth.13243_bb0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0031-1281039","article-title":"von Willebrand disease in the United States: a perspective from Wisconsin","volume":"37","author":"Flood","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13243_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/s-0031-1281032","article-title":"Diagnosis and management of von Willebrand disease in The Netherlands","volume":"37","author":"de Wee","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13243_bb0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jth.12160","article-title":"Weibel\u2010Palade bodies: a window to von Willebrand disease","volume":"11","author":"Valentijn","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2012-07-442285","article-title":"Unwinding the von Willebrand factor strings puzzle","volume":"121","author":"De Ceunynck","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0045","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1\u2010deamino\u20108\u2010D\u2010arginine vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0050","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1172\/JCI108788","article-title":"Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease","volume":"60","author":"Weiss","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13243_bb0055","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2012-06-435727","article-title":"Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells","volume":"121","author":"Starke","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0060","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2012-06-434373","article-title":"Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/bjh.13074","article-title":"Storage and secretion of naturally occurring von Willebrand factor A domain variants","volume":"167","author":"Groeneveld","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13243_bb0070","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2012-10-457507","article-title":"The C\u2010type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels","volume":"121","author":"Rydz","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0075","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"Sanders","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0080","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2012-09-455089","article-title":"VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease","volume":"121","author":"Eikenboom","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0085","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"key":"10.1111\/jth.13243_bb0095","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jth.12130","article-title":"The genetics of Canadian type 3 von Willebrand disease: further evidence for co\u2010dominant inheritance of mutant alleles","volume":"11","author":"Bowman","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0100","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.1995.00430130095010","article-title":"Usefulness of patient interview in bleeding disorders","volume":"155","author":"Sr\u00e1mek","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.13243_bb0105","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0110","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM\u20101 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0115","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2009.03499.x","article-title":"Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire","volume":"7","author":"Bowman","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1538-7836.2011.04265.x","article-title":"Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation","volume":"9","author":"Tosetto","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0125","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1111\/hae.12747","article-title":"Generation and optimization of the self\u2010administered bleeding assessment tool and its validation as a screening test for von Willebrand disease","volume":"21","author":"Deforest","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13243_bb0130","first-page":"1219","article-title":"Bleeding time. A guide to its diagnostic and clinical utility","volume":"113","author":"Burns","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/jth.13243_bb0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2010.08333.x","article-title":"The impact of bleeding history, von Willebrand factor and PFA\u2010100((R)) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM\u20101VWD","volume":"151","author":"Castaman","year":"2010","journal-title":"Br J Haematol"},{"issue":"Suppl. 2","key":"10.1111\/jth.13243_bb0140","first-page":"106","article-title":"Description of an in vitro platelet function analyzer\u2013PFA\u2010100","volume":"21","author":"Kundu","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13243_bb0145","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2006.01771.x","article-title":"Platelet function analyzer (PFA)\u2010100 closure time in the evaluation of platelet disorders and platelet function","volume":"4","author":"Hayward","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0150","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1538-7836.2004.00693.x","article-title":"Template bleeding time and PFA\u2010100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients","volume":"2","author":"Quiroga","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-0037-1614035","article-title":"von Willebrand disease in a pediatric\u2010based population \u2013 comparison of type 1 diagnostic criteria and use of the PFA\u2010100 and a von Willebrand factor\/collagen\u2010binding assay","volume":"84","author":"Dean","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0160","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/clinchem\/28.6.1356","article-title":"Enzyme immunoassay for factor VIII\u2010related antigen","volume":"28","author":"Cejka","year":"1982","journal-title":"Clin Chem"},{"key":"10.1111\/jth.13243_bb0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0037-1614468","article-title":"A new automated method for von Willebrand factor antigen measurement using latex particles","volume":"81","author":"Veyradier","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.thromres.2010.06.013","article-title":"Validation of a rapid test (VWF\u2010LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM\u20101VWD","volume":"126","author":"Castaman","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13243_bb0175","doi-asserted-by":"crossref","first-page":"e84810","DOI":"10.1371\/journal.pone.0084810","article-title":"Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: a study of ARIC and 1000 genome cohorts","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13243_bb0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MBC.0b013e3283367931","article-title":"Establishment of reference intervals for von Willebrand factor antigen and eight coagulation factors in a Korean population following the Clinical and Laboratory Standards Institute guidelines","volume":"21","author":"Jang","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13243_bb0185","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","article-title":"VWF mutations and new sequence variations identified in healthy controls are more frequent in the African\u2010American population","volume":"119","author":"Bellissimo","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0190","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0195","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0200","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/jth.12586","article-title":"von Willebrand disease and aging: an evolving phenotype","volume":"12","author":"Sanders","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0205","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/hae.12664","article-title":"Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease","volume":"21","author":"Rydz","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13243_bb0210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1160\/TH11-07-0481","article-title":"Haemostatic variables during normal menstrual cycle. A systematic review","volume":"107","author":"Knol","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0215","doi-asserted-by":"crossref","first-page":"e91687","DOI":"10.1371\/journal.pone.0091687","article-title":"Performance related factors are the main determinants of the von Willebrand factor response to exhaustive physical exercise","volume":"9","author":"van Loon","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13243_bb0220","doi-asserted-by":"crossref","first-page":"e2013052","DOI":"10.4084\/mjhid.2013.052","article-title":"Changes of von Willebrand factor during pregnancy in women with and without von Willebrand disease","volume":"5","author":"Castaman","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1111\/jth.13243_bb0225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0049-3848(89)90317-4","article-title":"von Willebrand factor is an acute phase reactant in man","volume":"53","author":"Pottinger","year":"1989","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13243_bb0230","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0235","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1172\/JCI107465","article-title":"Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content","volume":"52","author":"Weiss","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13243_bb0240","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet\u2010dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bod\u00f3","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0245","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/j.1538-7836.2010.04029.x","article-title":"Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol","volume":"8","author":"Hillarp","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0250","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1538-7836.2009.03594.x","article-title":"Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function","volume":"7","author":"Flood","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0255","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0260","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0037-1613765","article-title":"A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor","volume":"83","author":"Vanhoorelbeke","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0265","first-page":"77","article-title":"A sensitive ristocetin co\u2010factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici","year":"2004","journal-title":"Haematologica"},{"key":"10.1111\/jth.13243_bb0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/hae.12264","article-title":"A two\u2010centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen","volume":"20","author":"Stufano","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13243_bb0275","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain\u2010of\u2010function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0280","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","article-title":"Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin","volume":"25","author":"Patzke","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13243_bb0285","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1055\/s-0038-1657727","article-title":"von Willebrand factor activity detected in a monoclonal antibody\u2010based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use","volume":"78","author":"Murdock","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0290","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1055\/s-0037-1614064","article-title":"Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF\u2010capture systems","volume":"84","author":"Favaloro","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0295","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.thromres.2014.04.033","article-title":"Comparison of von Willebrand factor (VWF) activity VWF: Ac with VWF ristocetin cofactor activity VWF:RCo","volume":"134","author":"Geisen","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13243_bb0300","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/hae.12119","article-title":"Similarity in joint function limitation in Type 3 von Willebrand's disease and moderate haemophilia A","volume":"19","author":"Sood","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13243_bb0305","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand's disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13243_bb0310","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1160\/TH10-04-0213","article-title":"Prospective study of low\u2010dose ristocetin\u2010induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet\u2010type VWD in children","volume":"104","author":"Frontroth","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0315","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2141.2007.06850.x","article-title":"Differential identification of a rare form of platelet\u2010type (pseudo\u2010) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin\u2010induced\u2010platelet\u2010agglutination mixing assay and confirmed by genetic analysis","volume":"139","author":"Favaloro","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13243_bb0320","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2006-947866","article-title":"Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification","volume":"32","author":"Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13243_bb0325","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13243_bb0330","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1538-7836.2008.02945.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM\u20101VWD)","volume":"6","author":"Budde","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0335","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2141.2002.03488.x","article-title":"Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents","volume":"117","author":"Caron","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13243_bb0340","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13243_bb0345","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2014-11-610824","article-title":"Crucial role for the VWF A1 domain in binding to type IV collagen","volume":"125","author":"Flood","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0350","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1538-7836.2012.04746.x","article-title":"Critical von Willebrand factor A1 domain residues influence type VI collagen binding","volume":"10","author":"Flood","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"Pt 1","key":"10.1111\/jth.13243_bb0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/bj3240185","article-title":"von Willebrand factor binds to native collagen VI primarily via its A1 domain","volume":"324","author":"Hoylaerts","year":"1997","journal-title":"Biochem J"},{"key":"10.1111\/jth.13243_bb0360","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1160\/TH10-06-0360","article-title":"Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease","volume":"104","author":"Favaloro","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0365","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ijlh.12019","article-title":"Establishment and characterization of a new and stable collagen\u2010binding assay for the assessment of von Willebrand factor activity","volume":"35","author":"Ni","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.13243_bb0370","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1373\/clinchem.2012.199000","article-title":"Collagen binding provides a sensitive screen for variant von Willebrand disease","volume":"59","author":"Flood","year":"2013","journal-title":"Clin Chem"},{"key":"10.1111\/jth.13243_bb0375","doi-asserted-by":"crossref","first-page":"13497","DOI":"10.1016\/S0021-9258(18)80024-2","article-title":"In vitro multimerization of von Willebrand factor is triggered by low pH. Importance of the propolypeptide and free sulfhydryls","volume":"264","author":"Mayadas","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13243_bb0380","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1073\/pnas.84.7.1955","article-title":"Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells","volume":"84","author":"Wagner","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13243_bb0385","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood.V94.1.179.413k18_179_185","article-title":"von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation","volume":"94","author":"van Mourik","year":"1999","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0390","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0395","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM\u20101VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0400","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2141.2008.07311.x","article-title":"von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease","volume":"143","author":"Sztukowska","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13243_bb0405","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jth.12927","article-title":"CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease","volume":"13","author":"Sanders","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0410","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/jth.12885","article-title":"Shear stress\u2010independent binding of von Willebrand factor\u2010type 2B mutants p. R1306Q & p.V1316M to LRP1 explains their increased clearance","volume":"13","author":"Wohner","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0415","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1182\/blood.V85.11.3150.bloodjournal85113150","article-title":"The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor","volume":"85","author":"Vlot","year":"1995","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0420","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0037-1612981","article-title":"The factor VIII\/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor","volume":"87","author":"Eikenboom","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0425","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1160\/TH15-04-0282","article-title":"Molecular and clinical profile of von Willebrand disease in Spain (PCM\u2010EVW\u2010ES): proposal for a new diagnostic paradigm","volume":"115","author":"Batlle","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0430","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1365-2516.2009.02078.x","article-title":"Multiplex ligation\u2010dependent probe amplification to detect a large deletion within the von Willebrand gene","volume":"15","author":"Acquila","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13243_bb0435","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","article-title":"Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction","volume":"30","author":"Mancuso","year":"1991","journal-title":"Biochemistry"},{"key":"10.1111\/jth.13243_bb0440","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM\u20101VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0445","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.13243_bb0450","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13243_bb0455","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand disease","volume":"122","author":"James","year":"2013","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13243","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13243","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622045858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622045858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13243\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:15:36Z","timestamp":1761534936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622045858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1538783622045858"],"URL":"https:\/\/doi.org\/10.1111\/jth.13243","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developments in the diagnostic procedures for von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}